Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial

Published:2021-12 Issue:12 Volume:33 Page:e553-e560
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Mittal A.,Malik P.S.,Kumar S.,Saikia J.,Chitikela S.,Khurana S.,Bharti S.,Jain D.,Pathy S.,Thulkar S.,Kumar R.,Madan K.,Mohan A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. ICMR-NCDIR-NCRP Investigator Group. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India;Mathur;JCO Glob Oncol,2020

3. Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India;Malik;Asian Pac J Cancer Prev,2013

4. Before or after: evolving neoadjuvant approaches to locally advanced non-small cell lung cancer;Lewis;Front Oncol,2018

5. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications;Lim;Quant Imag Med Surg,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemoimmunotherapy for NSCLC;JAMA Oncology;2024-05-01

2. Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis;Frontiers in Oncology;2022-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP